We are live on ! Find out more
GDRX icon

GoodRx Holdings

170 hedge funds and large institutions have $633M invested in GoodRx Holdings in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more call options, than puts

Call options by funds: $4.22M | Put options by funds: $1.2M

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

13% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 47

1% more funds holding

Funds holding: 168170 (+2)

13.83% less ownership

Funds ownership: 144.32%130.49% (-14%)

36% less capital invested

Capital invested by funds: $988M → $633M (-$355M)

Holders
170
Holders Change
+2
Holders Change %
+1.19%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
53
Increased
46
Reduced
35
Closed
47
Calls
$4.22M
Puts
$1.2M
Net Calls
+$3.02M
Net Calls Change
+$930K
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
176
Gilder Gagnon Howe & Co
New York
-$1.57M -226,109 Closed
Bank of Montreal
177
Bank of Montreal
Ontario, Canada
-$1.13M -165,632 Closed
DB
178
Danske Bank
Denmark
-$963K -138,786 Closed
SCM
179
Sterling Capital Management
North Carolina
-$877K -126,338 Closed
TD Asset Management
180
TD Asset Management
Ontario, Canada
-$799K -116,674 Closed
SAM
181
Sectoral Asset Management
Quebec, Canada
-$805K -116,000 Closed
Walleye Trading
182
Walleye Trading
New York
-$634K -115,354 Closed
Vontobel Holding
183
Vontobel Holding
Switzerland
-$651K -93,750 Closed
SPS
184
Susquehanna Portfolio Strategies
Pennsylvania
-$646K -93,144 Closed
Jane Street
185
Jane Street
New York
-$539K -77,641 Closed
LIP
186
Liontrust Investment Partners
United Kingdom
-$520K -66,615 Closed
KNW
187
Kesler Norman & Wride
Utah
-$420K -60,535 Closed
CAMG
188
CWA Asset Management Group
Florida
-$370K -53,331 Closed
DTL
189
Dynamic Technology Lab
Singapore
-$308K -44,419 Closed
Mirae Asset Global Investments
190
Mirae Asset Global Investments
South Korea
-$180K -26,300 Closed
A
191
AlphaQuest
New York
-$160K -23,044 Closed
WG
192
Winton Group
United Kingdom
-$131K -18,934 Closed
DFCM
193
Dark Forest Capital Management
Puerto Rico
-$97.9K -14,111 Closed
Handelsbanken Fonder
194
Handelsbanken Fonder
Sweden
-$78K -11,200 Closed
VT
195
Vise Technologies
New York
-$75.3K -10,855 Closed
EWA
196
EP Wealth Advisors
California
-$73.2K -10,547 Closed
AF
197
Advisornet Financial
Minnesota
-$69.4K -10,000 Closed
NEI
198
Northwest & Ethical Investments
Ontario, Canada
-$68.7K -9,902 Closed
NC
199
nVerses Capital
Florida
-$33.3K -4,800 Closed
QL
200
Quarry LP
New York
-$20.2K -2,907 Closed

GDRX Hedge Fund Activity: Q4 2024 in Review

170 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2024, worth a combined $633M — down 36% from $988M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GDRX positions and 47 closed out — a net gain of 6 holders — while 46 added to existing stakes and 35 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $6.93M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $26.5M sold.

  • 170 institutional investors held GoodRx Holdings (GDRX) as of Q4 2024, up from 168 in Q3 2024.
  • Funds reported $633M of GoodRx Holdings stock for Q4 2024, down 36% quarter-over-quarter.
  • 53 funds opened new GoodRx Holdings positions in Q4 2024 and 47 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q4 2024 was ClearBridge Investments, an estimated $6.93M added.
  • The largest GoodRx Holdings seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2024.